ENMD-981693 Completed Phase 2 Trials for Advanced / Metastatic / Soft Tissue Sarcoma Treatment

IndicationsStatusPurposePhase
CompletedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT01719744Study of ENMD-2076 in Patients With Advanced/Metastatic Soft Tissue Sarcoma